Old Web
English
Sign In
Acemap
>
authorDetail
>
Maureen Klein
Maureen Klein
University of Maryland, Baltimore
Medicine
Immunology
Maintenance therapy
Consolidation Chemotherapy
Tipifarnib
4
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
2008
Clinical Cancer Research
Judith E. Karp
B. Douglas Smith
Ivana Gojo
Jeffrey E. Lancet
Jacqueline Greer
Maureen Klein
Lawrence E. Morris
Mark J. Levis
Steven D. Gore
John J. Wright
Elizabeth Garrett-Mayer
Show All
Source
Cite
Save
Citations (36)
Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of of the Hsp-90 inhibitor, KOS-1022 (17-DMAG), in patients with refractory hematological malignancies
2006
Journal of Clinical Oncology
Jeffrey E. Lancet
Ivana Gojo
Maria R. Baer
Michelle K. Burton
Maureen Klein
C. Nowadly
M. Gorre
Z. Zhong
Robert G. Johnson
Alison L. Hannah
Show All
Source
Cite
Save
Citations (5)
1